{"parse":{"title":"Acquired generalized lipodystrophy","pageid":21894306,"revid":845118550,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background:#ccc\">Acquired generalized lipodystrophy</th></tr><tr><th scope=\"row\">Synonyms</th><td>\nLawrence-Seip syndrome</td></tr></tbody></table>\n<p><b>Acquired generalized lipodystrophy</b> (also known as \"Lawrence syndrome,\"<sup id=\"cite_ref-Bolognia_1-0\" class=\"reference\"><a href=\"#cite_note-Bolognia-1\">&#91;1&#93;</a></sup> and \"Lawrence\u2013Seip syndrome\",<sup id=\"cite_ref-Bolognia_1-1\" class=\"reference\"><a href=\"#cite_note-Bolognia-1\">&#91;1&#93;</a></sup> abbreviation: AGL) is a rare <a href=\"/wiki/Skin_condition\" class=\"mw-redirect\" title=\"Skin condition\">skin condition</a> that appears during childhood or adolescence, characterized by <a href=\"/wiki/Lipodystrophy\" title=\"Lipodystrophy\">fat loss</a> affecting large areas of the body, particularly the face, arms, and legs.<sup id=\"cite_ref-Andrews_2-0\" class=\"reference\"><a href=\"#cite_note-Andrews-2\">&#91;2&#93;</a></sup><sup class=\"reference\" style=\"white-space:nowrap;\">:<span>496</span></sup> There are 4 types of <a href=\"/wiki/Lipodystrophy\" title=\"Lipodystrophy\">lipodystrophy</a> based on its onset and areas affected: acquired or <a href=\"/wiki/Inherited_disease\" class=\"mw-redirect\" title=\"Inherited disease\">inherited</a> (<a href=\"/wiki/Congenital_disorder\" class=\"mw-redirect\" title=\"Congenital disorder\">congenital</a> or familial), and generalized or <a href=\"/wiki/Partial_lipodystrophy\" class=\"mw-redirect\" title=\"Partial lipodystrophy\">partial</a>. Both acquired or inherited lipodystrophy present as loss of <a href=\"/wiki/Adipose_tissue\" title=\"Adipose tissue\">adipose tissues</a>. The near-total loss of <a href=\"/wiki/Subcutaneous_tissue\" title=\"Subcutaneous tissue\">subcutaneous</a> <a href=\"/wiki/Adipose_tissue\" title=\"Adipose tissue\">adipose tissue</a> is termed generalized lipodystrophy while the selective loss of adipose tissues is denoted as partial lipodystrophy.<sup id=\"cite_ref-:7_3-0\" class=\"reference\"><a href=\"#cite_note-:7-3\">&#91;3&#93;</a></sup> Thus, as the name suggests, AGL is a near-total deficiency of adipose tissues in the body that is developed later in life. It is an extremely rare disease that only about 100 cases are reported worldwide.<sup id=\"cite_ref-:0_4-0\" class=\"reference\"><a href=\"#cite_note-:0-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-:1_5-0\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup> There are three main etiologies of AGL suspected: <a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">autoimmune</a>, <a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">panniculitis</a>-associated, or <a href=\"/wiki/Idiopathy\" class=\"mw-redirect\" title=\"Idiopathy\">idiopathic</a>.<sup id=\"cite_ref-:2_6-0\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup> After its onset, the disease progresses over a few days, weeks, months, or even in years.<sup id=\"cite_ref-:2_6-1\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup> Clinical presentations of AGL are similar to other lipodystrophies, including metabolic complications and hypoleptinemia.<sup id=\"cite_ref-:2_6-2\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:1_5-1\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup> Treatments are also similar and mainly supportive for symptomatic alleviation. Although HIV- or drug-induced lipodystrophy are a type of acquired lipodystrophy, its origin is very specific and distinct hence is usually not discussed with AGL (see <a href=\"/wiki/HIV-associated_lipodystrophy\" title=\"HIV-associated lipodystrophy\">HIV-Associated Lipodystrophy</a>).\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Symptoms\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Symptoms</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Cause\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Cause</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Panniculitis-associated_AGL\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Panniculitis-associated AGL</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Autoimmune-associated_AGL\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Autoimmune-associated AGL</span></a></li>\n<li class=\"toclevel-2 tocsection-5\"><a href=\"#Idiopathic_AGL\"><span class=\"tocnumber\">2.3</span> <span class=\"toctext\">Idiopathic AGL</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Mechanism\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Mechanism</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Diagnosis\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Diagnosis</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#Treatment_and_prognosis\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Treatment and prognosis</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#Recent_research\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Recent research</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#See_also\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-12\"><a href=\"#External_links\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Symptoms\">Symptoms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=1\" title=\"Edit section: Symptoms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The clinical presentation is similar to people with <a href=\"/wiki/Congenital_lipodystrophy\" class=\"mw-redirect\" title=\"Congenital lipodystrophy\">congenital lipodystrophy</a>: the only difference is that AGL patients are born with normal fat distribution and symptoms develop in childhood and adolescence years and rarely begins after 30 years of age.<sup id=\"cite_ref-:2_6-3\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:9_7-0\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> Females are more often affected than males, with ratio being 3:1.<sup id=\"cite_ref-:1_5-2\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-:2_6-4\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:5_8-0\" class=\"reference\"><a href=\"#cite_note-:5-8\">&#91;8&#93;</a></sup>\n</p><p>The hallmark characteristics are widespread loss of <a href=\"/wiki/Subcutaneous_tissue\" title=\"Subcutaneous tissue\">subcutaneous fat</a>, ectopic fat deposition, <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a> deficiency, and severe <a href=\"/wiki/Metabolic_syndrome\" title=\"Metabolic syndrome\">metabolic abnormalities</a> such as <a href=\"/wiki/Insulin_resistance\" title=\"Insulin resistance\">insulin resistance</a>.<sup id=\"cite_ref-:8_9-0\" class=\"reference\"><a href=\"#cite_note-:8-9\">&#91;9&#93;</a></sup> Subcutaneous fat loss in AGL patients are visible in all parts of the body. AGL mostly affects face and the extremities and may look sunken or swollen in the eyes.<sup id=\"cite_ref-:2_6-5\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:5_8-1\" class=\"reference\"><a href=\"#cite_note-:5-8\">&#91;8&#93;</a></sup> However, the degree and location of severity may vary by person.<sup id=\"cite_ref-:2_6-6\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:5_8-2\" class=\"reference\"><a href=\"#cite_note-:5-8\">&#91;8&#93;</a></sup> Especially, intra-abdominal fat loss is variable.<sup id=\"cite_ref-:9_7-1\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> As subcutaneous fat is lost, affected areas show prominent structures of veins and muscle. Those with panniculitis-associated AGL may present erythematous nodules.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p><p>Metabolic complications include insulin resistance, high metabolic rate, and uncontrolled lipid levels such as hypertriglyceridemia, low HDL, and high LDL. Patients may develop <a href=\"/wiki/Diabetes_mellitus\" title=\"Diabetes mellitus\">diabetes mellitus</a> secondary to <a href=\"/wiki/Insulin_resistance\" title=\"Insulin resistance\">insulin resistance</a>.\n</p><p>Recent case reports revealed that <a href=\"/wiki/Lymphoma\" title=\"Lymphoma\">lymphoma</a> is present in some patients but its prevalence is not known at this time.<sup id=\"cite_ref-:7_3-1\" class=\"reference\"><a href=\"#cite_note-:7-3\">&#91;3&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Cause\">Cause</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=2\" title=\"Edit section: Cause\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>There is no known cause for this disease; however, three origins of AGL are generally suspected: <a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">panniculitis</a>-associated, <a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">autoimmune</a>-associated, and <a href=\"/wiki/Idiopathy\" class=\"mw-redirect\" title=\"Idiopathy\">idiopathic</a> AGLs.<sup id=\"cite_ref-:1_5-3\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup> Triggers may include <a href=\"/wiki/Infection\" title=\"Infection\">infections</a> that aggravate the <a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">panniculitis</a>, or any disease state that can induce <a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">autoimmunity</a>. Overlap between panniculitis and autoimmune types also exists.<sup id=\"cite_ref-:9_7-2\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> Another theory suggest that AGL is an autoimmune disease itself, as panniculitis can be described as an autoimmune disease, however its triggering factors remains to be unknown.<sup id=\"cite_ref-:9_7-3\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> Underlying <a href=\"/wiki/Genetics\" title=\"Genetics\">genetic</a> factor may be associated; however neither confirmed nor rejected.<sup id=\"cite_ref-:1_5-4\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Panniculitis-associated_AGL\"><a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">Panniculitis</a>-associated AGL</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=3\" title=\"Edit section: Panniculitis-associated AGL\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>About 25% of previously reported AGL is associated with <a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">panniculitis</a>.<sup id=\"cite_ref-:2_6-7\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:3_11-0\" class=\"reference\"><a href=\"#cite_note-:3-11\">&#91;11&#93;</a></sup> <a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">Panniculitis</a> is an inflammatory nodules of the subcutaneous fat, and in this type of AGL, adipose destruction originates locally at the infection or inflammation site and develops into <a href=\"/wiki/Lipodystrophy\" title=\"Lipodystrophy\">generalized lipodystrophy</a>.<sup id=\"cite_ref-:3_11-1\" class=\"reference\"><a href=\"#cite_note-:3-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-:9_7-4\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Autoimmune-associated_AGL\"><a href=\"/wiki/Autoimmunity\" title=\"Autoimmunity\">Autoimmune</a>-associated AGL</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=4\" title=\"Edit section: Autoimmune-associated AGL\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>AGL with autoimmune origin is responsible for about 25% of all AGL reports.<sup id=\"cite_ref-:2_6-8\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:3_11-2\" class=\"reference\"><a href=\"#cite_note-:3-11\">&#91;11&#93;</a></sup> Those with autoimmune origin stems from other autoimmune diseases, most commonly with <a href=\"/wiki/Juvenile_dermatomyositis\" title=\"Juvenile dermatomyositis\">juvenile dermatomyositis</a> and <a href=\"/wiki/Autoimmune_hepatitis\" title=\"Autoimmune hepatitis\">autoimmune hepatitis</a>, but also occurs with <a href=\"/wiki/Rheumatoid_arthritis\" title=\"Rheumatoid arthritis\">rheumatoid arthritis</a>, <a href=\"/wiki/Systemic_lupus_erythematosus\" title=\"Systemic lupus erythematosus\">systemic lupus erythematous</a>, and <a href=\"/wiki/Sj%C3%B6gren_syndrome\" title=\"Sj\u00f6gren syndrome\">Sjogren syndrome</a>.<sup id=\"cite_ref-:3_11-3\" class=\"reference\"><a href=\"#cite_note-:3-11\">&#91;11&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Idiopathic_AGL\"><a href=\"/wiki/Idiopathy\" class=\"mw-redirect\" title=\"Idiopathy\">Idiopathic</a> AGL</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=5\" title=\"Edit section: Idiopathic AGL\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Although idiopathic AGL accounts for about 50% of all AGL, it can vary in its origin and its is unclear how it develops.<sup id=\"cite_ref-:2_6-9\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:3_11-4\" class=\"reference\"><a href=\"#cite_note-:3-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-:4_12-0\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup>\n</p><p>No known preventive measurement has been reported.\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanism\">Mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=6\" title=\"Edit section: Mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The exact pathophysiologic mechanism is mostly unknown; however, each of three main origins, autoimmune, panniculitis, or idiopathic, may have different mechanisms of pathogenesis.<sup id=\"cite_ref-:2_6-10\" class=\"reference\"><a href=\"#cite_note-:2-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-:3_11-5\" class=\"reference\"><a href=\"#cite_note-:3-11\">&#91;11&#93;</a></sup>\n</p><p>Normally, <a href=\"/wiki/Adipose_tissue\" title=\"Adipose tissue\">adipose tissues</a> contain <a href=\"/wiki/Adipocyte\" title=\"Adipocyte\">adipocytes</a> to store fat for energy during <a href=\"/wiki/Fasting\" title=\"Fasting\">fasting</a> period and release <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a> to regulate <a href=\"/wiki/Homeostasis\" title=\"Homeostasis\">homeostasis</a> of energy and sensitize insulin. In AGL patients, adipose tissues are insufficient and leads to fat deposition in non-adipose tissues, such as <a href=\"/wiki/Muscle\" title=\"Muscle\">muscle</a> or <a href=\"/wiki/Liver\" title=\"Liver\">liver</a>, resulting in <a href=\"/wiki/Hypertriglyceridemia\" title=\"Hypertriglyceridemia\">hypertriglyceridemia</a>. Continuous elevation in <a href=\"/wiki/Triglyceride\" title=\"Triglyceride\">triglyceride</a> levels further contributes to metabolic problems including <a href=\"/wiki/Insulin_resistance\" title=\"Insulin resistance\">insulin resistance</a>.<sup id=\"cite_ref-:4_12-1\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup> As the level of <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a> in the body is proportional to the amount of adipose tissue present, AGL patients also have a deficiency of <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a> which contributes to excessive eating and worsens the <a href=\"/wiki/Metabolic_syndrome\" title=\"Metabolic syndrome\">metabolic syndrome</a>.<sup id=\"cite_ref-:4_12-2\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup>\n</p><p>In a few patients with AGL, the presence of <a href=\"/wiki/Antibody\" title=\"Antibody\">antibodies</a> against <a href=\"/wiki/Adipocyte\" title=\"Adipocyte\">adipocyte</a> has been identified.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Diagnosis\">Diagnosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=7\" title=\"Edit section: Diagnosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Diagnosis is made comprehensively, together with visual observation, body fat assessment, a review of lab panels consisting of A1c, glucose, lipid, and patient history.\n</p><p>Caliper measurements of skinfold thickness is recommended to quantify fat loss as a supportive information.<sup id=\"cite_ref-:9_7-5\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> In this measurement, skinfold thickness of less than 10mm for men and 22mm for women at the anterior thigh is suggestive cutoff for the diagnosis of lipodystrophy.<sup id=\"cite_ref-:9_7-6\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> Less commonly, biphotonic absorptiometry and <a href=\"/wiki/Magnetic_resonance_imaging\" title=\"Magnetic resonance imaging\">magnetic resonance imaging</a> (MRI) can be done for the measurement of body fat.<sup id=\"cite_ref-:1_5-5\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup>\n</p><p>Other forms of insulin resistance may be assessed for <a href=\"/wiki/Differential_diagnosis\" title=\"Differential diagnosis\">differential diagnosis</a>.<sup id=\"cite_ref-:1_5-6\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup> Resistance to conventional therapy for hyperglycemia and hypertriglyceridemia serves as an indication for lipodystrophy. Specifically, the diagnosis is strongly considered for those requiring \u2265200 units/day of insulin and persistent elevation of \u2265250&#160;mg/dl of triglyceride levels.<sup id=\"cite_ref-:9_7-7\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup>\n</p><p>The use of leptin levels should be carefully approached.<sup id=\"cite_ref-:9_7-8\" class=\"reference\"><a href=\"#cite_note-:9-7\">&#91;7&#93;</a></sup> While low leptin levels are helpful for making the diagnosis, they are not specific for the lipodystrophy. High leptin levels can help excluding the possible lipodystrophy, but there is no well-established standardized leptin ranges.\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment_and_prognosis\">Treatment and prognosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=8\" title=\"Edit section: Treatment and prognosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Initial and general approach for AGL patients are to treat the metabolic complications such as <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a>-replacement therapy and/or to control the abnormal levels of <a href=\"/wiki/Lipid\" title=\"Lipid\">lipids</a> or <a href=\"/wiki/Glucose\" title=\"Glucose\">glucose</a> levels.<sup id=\"cite_ref-:4_12-3\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup> <a href=\"/wiki/Anti-diabetic_medication\" title=\"Anti-diabetic medication\">Anti-diabetic medications</a> such as <a href=\"/wiki/Insulin\" title=\"Insulin\">insulin</a>, <a href=\"/wiki/Metformin\" title=\"Metformin\">metformin</a>, or <a href=\"/wiki/Thiazolidinedione\" title=\"Thiazolidinedione\">thiazolidinediones</a> are used for insulin-resistance or high glucose levels, or <a href=\"/wiki/Statin\" title=\"Statin\">statins</a> or <a href=\"/wiki/Fibrate\" title=\"Fibrate\">fibrates</a> are used for <a href=\"/wiki/Hyperlipidemia\" title=\"Hyperlipidemia\">hyperlipidemia</a>. If symptoms persist, <a href=\"/wiki/Metreleptin\" title=\"Metreleptin\">metreleptin</a> can be prescribed.\n</p><p><a href=\"/wiki/Metreleptin\" title=\"Metreleptin\">Metreleptin</a> (MYALEPT<b><sup>\u00ae</sup>)</b> is a recombinant human <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a> analog and was approved by FDA in 2014 for generalized lipodystrophy as an adjunct therapy to diet to treat the complication of <a href=\"/wiki/Leptin\" title=\"Leptin\">leptin</a> deficiency.<sup id=\"cite_ref-:6_14-0\" class=\"reference\"><a href=\"#cite_note-:6-14\">&#91;14&#93;</a></sup> It is the only drug option approved for generalized lipodystrophy-related symptoms and is not intended to use for patients with <a href=\"/wiki/HIV-associated_lipodystrophy\" title=\"HIV-associated lipodystrophy\">HIV-related lipodystrophy</a> or complications of <a href=\"/wiki/Partial_lipodystrophy\" class=\"mw-redirect\" title=\"Partial lipodystrophy\">partial lipodystrophy</a>.<sup id=\"cite_ref-:6_14-1\" class=\"reference\"><a href=\"#cite_note-:6-14\">&#91;14&#93;</a></sup> Although it is a recombinant human leptin analog, it is not completely the same as natural leptin as it is produced in <i><a href=\"/wiki/Escherichia_coli\" title=\"Escherichia coli\">e. coli</a></i> and has added <a href=\"/wiki/Methionine\" title=\"Methionine\">methionine</a> residues at is amino terminus.<sup id=\"cite_ref-:6_14-2\" class=\"reference\"><a href=\"#cite_note-:6-14\">&#91;14&#93;</a></sup> It works by binding to the human <a href=\"/wiki/Leptin_receptor\" title=\"Leptin receptor\">leptin receptor</a>, <a href=\"/wiki/Leptin_receptor\" title=\"Leptin receptor\">ObR</a>, and activates the <a href=\"/wiki/Receptor_(biochemistry)\" title=\"Receptor (biochemistry)\">receptor</a>.<sup id=\"cite_ref-:6_14-3\" class=\"reference\"><a href=\"#cite_note-:6-14\">&#91;14&#93;</a></sup> The receptor belongs to the Class I <a href=\"/wiki/Cytokine\" title=\"Cytokine\">cytokine family</a> and signals the <a href=\"/wiki/JAK-STAT_signaling_pathway\" title=\"JAK-STAT signaling pathway\">JAK/STAT pathway</a>. It is available as 11.3&#160;mg powder in a vial for subcutaneous injection upon reconstitution and needs to be protected from the light. For treatment, patients and their doctors need to be enrolled and certified in the <a href=\"/wiki/Metreleptin\" title=\"Metreleptin\">Myalept</a><b><sup>\u00ae</sup></b> <a href=\"/wiki/Risk_evaluation_and_mitigation_strategy\" class=\"mw-redirect\" title=\"Risk evaluation and mitigation strategy\">Risk Evaluation and Mitigation Strategy (REMS)</a> Program because people on this treatment has a risk of developing anti-metreleptin <a href=\"/wiki/Antibody\" title=\"Antibody\">antibodies</a> that decrease the effectiveness of metreleptin, and increased risk of <a href=\"/wiki/Lymphoma\" title=\"Lymphoma\">lymphoma</a>.<sup id=\"cite_ref-:6_14-4\" class=\"reference\"><a href=\"#cite_note-:6-14\">&#91;14&#93;</a></sup> Clinical study with GL patients who took <a href=\"/wiki/Metreleptin\" title=\"Metreleptin\">metreleptin</a> had increased <a href=\"/wiki/Insulin\" title=\"Insulin\">insulin</a> sensitivity, as indicated by decreased <a href=\"/wiki/Glycated_hemoglobin\" title=\"Glycated hemoglobin\">HbA1c</a> and fasting glucose level, and reduced caloric intake as well as fasting <a href=\"/wiki/Triglyceride\" title=\"Triglyceride\">triglyceride</a> levels.<sup id=\"cite_ref-:4_12-4\" class=\"reference\"><a href=\"#cite_note-:4-12\">&#91;12&#93;</a></sup>\n</p><p><a href=\"/wiki/Plasmapheresis\" title=\"Plasmapheresis\">Plasmapheresis</a> was previously an option for lowering extremely high <a href=\"/wiki/Triglyceride\" title=\"Triglyceride\">triglyceride</a> levels for preventing <a href=\"/wiki/Pancreatitis\" title=\"Pancreatitis\">pancreatitis</a> and painful <a href=\"/wiki/Xanthoma\" title=\"Xanthoma\">xanthoma</a>, but its use has been decreased after the approval of metreleptin.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>\n</p><p>Cosmetic treatments, such as <a href=\"/wiki/Facial_reconstruction\" class=\"mw-redirect\" title=\"Facial reconstruction\">facial reconstruction</a> or <a href=\"/wiki/Implant_(body_modification)\" title=\"Implant (body modification)\">implant</a>s, can be done to replace <a href=\"/wiki/Adipose_tissue\" title=\"Adipose tissue\">adipose tissues</a>.\n</p><p>Lifestyle modifications are also recommended, including changes into less fat diet and exercise.\n</p><p>The <a href=\"/wiki/Prognosis\" title=\"Prognosis\">prognosis</a> of the disease is unknown as of December, 2017.<sup id=\"cite_ref-:1_5-7\" class=\"reference\"><a href=\"#cite_note-:1-5\">&#91;5&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Recent_research\">Recent research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=9\" title=\"Edit section: Recent research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Many researches for the treatment of lipodystrophy focus on the safety and efficacy of leptin replacement therapy and the outlook is positive in many studies.\n</p><p>According to a prospective, open-label clinical study at the NIH, metreleptin decreased the fasting glucose level from 180&#160;mg/dL to 121&#160;mg/dL, HbA1c from 8.4% to 6.4%, total cholesterol from 214&#160;mg/dL to 146&#160;mg/dL, and triglycerides from 467 (200-847)mg/dL to 180 (106-312)mg/dL after 12 months of use (p&lt;0.001).<sup id=\"cite_ref-:10_16-0\" class=\"reference\"><a href=\"#cite_note-:10-16\">&#91;16&#93;</a></sup> Patients also had decreased use of anti-diabetic medications, lipid-lowering medications, and insulin (p&lt;0.001).<sup id=\"cite_ref-:10_16-1\" class=\"reference\"><a href=\"#cite_note-:10-16\">&#91;16&#93;</a></sup> In other clinical reports studying 3 patients diagnosed with AGL accompanied by hypoleptinemia, uncontrolled diabetes, and hypertriglyceridemia who were treated with metreleptin for 12\u2013168 weeks, patients had great reduction in HbA1c, from 10.9% to 5.8%, and had normalized serum triglycerides with a mean decline of 90%. Patients reported improved quality of life and reduced need for other medications without significant adverse effects.<sup id=\"cite_ref-:8_9-1\" class=\"reference\"><a href=\"#cite_note-:8-9\">&#91;9&#93;</a></sup>\n</p><p>One research published in 2017 reported an middle-aged patient developed AGL after treatment and recovery for autoimmune thrombocytopenia that included immunoglobulin therapy and prednisone,<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> which suggests the autoimmune trigger may contribute to the development of AGL.\n</p><p>Other researches focus on genetics of lipodystrophy; however its relevance to acquired generalized lipodystrophy has not been confirmed so far. One clinical report published in July 2017 stated two brothers with juvenile-onset generalized lipodystrophy was due to <a href=\"/wiki/Lamin\" title=\"Lamin\">lamin</a> C-specific mutation but it is unknown at this point if this will fall into acquired or familial lipodystrophy.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup>\n</p><p>There has been many published case reports. Meta-analysis of published case reports published within the decade will be very helpful in establishing patient demographic, etiologies, and prognosis of the diagnosis.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=10\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Lipodystrophy\" title=\"Lipodystrophy\">Lipodystrophy</a></li>\n<li><a href=\"/wiki/List_of_cutaneous_conditions\" title=\"List of cutaneous conditions\">List of cutaneous conditions</a></li>\n<li><a href=\"/wiki/HIV-associated_lipodystrophy\" title=\"HIV-associated lipodystrophy\">HIV-associated lipodystrophy</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=11\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Bolognia-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bolognia_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bolognia_1-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). <i>Dermatology: 2-Volume Set</i>. St. Louis: Mosby. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/1-4160-2999-0\" title=\"Special:BookSources/1-4160-2999-0\">1-4160-2999-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Dermatology%3A+2-Volume+Set&amp;rft.place=St.+Louis&amp;rft.pub=Mosby&amp;rft.date=2007&amp;rft.isbn=1-4160-2999-0&amp;rft.au=Rapini%2C+Ronald+P.&amp;rft.au=Bolognia%2C+Jean+L.&amp;rft.au=Jorizzo%2C+Joseph+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Andrews-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Andrews_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">James, William D.; Berger, Timothy G.;  et al. (2006). <i>Andrews' Diseases of the Skin: clinical Dermatology</i>. Saunders Elsevier. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-7216-2921-0\" title=\"Special:BookSources/0-7216-2921-0\">0-7216-2921-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Andrews%27+Diseases+of+the+Skin%3A+clinical+Dermatology&amp;rft.pub=Saunders+Elsevier&amp;rft.date=2006&amp;rft.isbn=0-7216-2921-0&amp;rft.au=James%2C+William+D.&amp;rft.au=Berger%2C+Timothy+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:7-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:7_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:7_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Brown, Rebecca J.; Chan, Jean L.; Jaffe, Elaine S.; Cochran, Elaine; DePaoli, Alex M.; Gautier, Jean-Francois; Goujard, Cecile; Vigouroux, Corinne; Gorden, Phillip (2016-01-02). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.3109/10428194.2015.1040015\">\"Lymphoma in acquired generalized lipodystrophy\"</a>. <i>Leukemia &amp; Lymphoma</i>. <b>57</b> (1): 45\u201350. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/10428194.2015.1040015\">10.3109/10428194.2015.1040015</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4755279\">4755279</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25864863\">25864863</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Leukemia+%26+Lymphoma&amp;rft.atitle=Lymphoma+in+acquired+generalized+lipodystrophy&amp;rft.volume=57&amp;rft.issue=1&amp;rft.pages=45-50&amp;rft.date=2016-01-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4755279&amp;rft_id=info%3Apmid%2F25864863&amp;rft_id=info%3Adoi%2F10.3109%2F10428194.2015.1040015&amp;rft.aulast=Brown&amp;rft.aufirst=Rebecca+J.&amp;rft.au=Chan%2C+Jean+L.&amp;rft.au=Jaffe%2C+Elaine+S.&amp;rft.au=Cochran%2C+Elaine&amp;rft.au=DePaoli%2C+Alex+M.&amp;rft.au=Gautier%2C+Jean-Francois&amp;rft.au=Goujard%2C+Cecile&amp;rft.au=Vigouroux%2C+Corinne&amp;rft.au=Gorden%2C+Phillip&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.3109%2F10428194.2015.1040015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-:0_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Garg, Abhimanyu (2004-03-18). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1056/NEJMra025261\">\"Acquired and Inherited Lipodystrophies\"</a>. <i>New England Journal of Medicine</i>. <b>350</b> (12): 1220\u20131234. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/nejmra025261\">10.1056/nejmra025261</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15028826\">15028826</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Acquired+and+Inherited+Lipodystrophies&amp;rft.volume=350&amp;rft.issue=12&amp;rft.pages=1220-1234&amp;rft.date=2004-03-18&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmra025261&amp;rft_id=info%3Apmid%2F15028826&amp;rft.aulast=Garg&amp;rft.aufirst=Abhimanyu&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1056%2FNEJMra025261&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_5-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:1_5-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:1_5-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:1_5-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:1_5-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-:1_5-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-:1_5-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">RESERVED, INSERM US14 -- ALL RIGHTS. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79086\">\"Orphanet: Acquired generalized lipodystrophy\"</a>. <i>www.orpha.net</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-11-07</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.orpha.net&amp;rft.atitle=Orphanet%3A+Acquired+generalized+lipodystrophy&amp;rft.aulast=RESERVED&amp;rft.aufirst=INSERM+US14+--+ALL+RIGHTS&amp;rft_id=http%3A%2F%2Fwww.orpha.net%2Fconsor%2Fcgi-bin%2FOC_Exp.php%3Flng%3DEN%26Expert%3D79086&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:2_6-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:2_6-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:2_6-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:2_6-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-:2_6-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-:2_6-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-:2_6-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-:2_6-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-:2_6-10\"><sup><i><b>k</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hussain, Iram; Garg, Abhimanyu (2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S0889852916300706\">\"Lipodystrophy Syndromes\"</a>. <i>Endocrinology and Metabolism Clinics of North America</i>. <b>45</b> (4): 783\u2013797. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ecl.2016.06.012\">10.1016/j.ecl.2016.06.012</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27823605\">27823605</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrinology+and+Metabolism+Clinics+of+North+America&amp;rft.atitle=Lipodystrophy+Syndromes&amp;rft.volume=45&amp;rft.issue=4&amp;rft.pages=783-797&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ecl.2016.06.012&amp;rft_id=info%3Apmid%2F27823605&amp;rft.aulast=Hussain&amp;rft.aufirst=Iram&amp;rft.au=Garg%2C+Abhimanyu&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0889852916300706&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:9-7\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:9_7-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:9_7-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:9_7-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:9_7-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:9_7-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:9_7-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-:9_7-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-:9_7-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-:9_7-8\"><sup><i><b>i</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Handelsman, Yehuda; Oral, Elif A.; Bloomgarden, Zachary T.; Brown, Rebecca J.; Chan, Jean L.; Einhorn, Daniel; Garber, Alan J.; Garg, Abhimanyu; Garvey, W. Timothy (2013). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4108221\">\"THE CLINICAL APPROACH TO THE DETECTION OF LIPODYSTROPHY \u2013 AN AACE CONSENSUS STATEMENT\"</a>. <i>Endocrine practice&#160;: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists</i>. <b>19</b> (1): 107\u2013116. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4158/endp.19.1.v767575m65p5mr06\">10.4158/endp.19.1.v767575m65p5mr06</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4108221\">4108221</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23435042\">23435042</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine+practice+%3A+official+journal+of+the+American+College+of+Endocrinology+and+the+American+Association+of+Clinical+Endocrinologists&amp;rft.atitle=THE+CLINICAL+APPROACH+TO+THE+DETECTION+OF+LIPODYSTROPHY+%E2%80%93+AN+AACE+CONSENSUS+STATEMENT&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=107-116&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4108221&amp;rft_id=info%3Apmid%2F23435042&amp;rft_id=info%3Adoi%2F10.4158%2Fendp.19.1.v767575m65p5mr06&amp;rft.aulast=Handelsman&amp;rft.aufirst=Yehuda&amp;rft.au=Oral%2C+Elif+A.&amp;rft.au=Bloomgarden%2C+Zachary+T.&amp;rft.au=Brown%2C+Rebecca+J.&amp;rft.au=Chan%2C+Jean+L.&amp;rft.au=Einhorn%2C+Daniel&amp;rft.au=Garber%2C+Alan+J.&amp;rft.au=Garg%2C+Abhimanyu&amp;rft.au=Garvey%2C+W.+Timothy&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4108221&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:5-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:5_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:5_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:5_8-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/oclc/995848612\"><i>Greenspan's basic &amp; clinical endocrinology</i></a>. Gardner, David G.,, Shoback, Dolores M.,, Greenspan, Francis S. (Francis Sorrel), 1920- (Tenth ed.). [New York]. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9781259589287\" title=\"Special:BookSources/9781259589287\">9781259589287</a>. <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/oclc/995848612\">995848612</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Greenspan%27s+basic+%26+clinical+endocrinology&amp;rft.place=%5BNew+York%5D&amp;rft.edition=Tenth&amp;rft_id=info%3Aoclcnum%2F995848612&amp;rft.isbn=9781259589287&amp;rft_id=https%3A%2F%2Fwww.worldcat.org%2Foclc%2F995848612&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:8-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:8_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:8_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Musso, Carla; Major, Maria Laura; Andres, Eugenia; Simha, Vinaya (2017-01-05). <a rel=\"nofollow\" class=\"external text\" href=\"http://journals.sagepub.com/doi/10.4137/CCRep.S40196\">\"Metreleptin Treatment in Three Patients with Generalized Lipodystrophy\"</a>. <i>Clinical Medicine Insights: Case Reports</i>. <b>9</b>: CCRep.S40196. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4137/ccrep.s40196\">10.4137/ccrep.s40196</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Medicine+Insights%3A+Case+Reports&amp;rft.atitle=Metreleptin+Treatment+in+Three+Patients+with+Generalized+Lipodystrophy&amp;rft.volume=9&amp;rft.pages=CCRep.S40196&amp;rft.date=2017-01-05&amp;rft_id=info%3Adoi%2F10.4137%2Fccrep.s40196&amp;rft.aulast=Musso&amp;rft.aufirst=Carla&amp;rft.au=Major%2C+Maria+Laura&amp;rft.au=Andres%2C+Eugenia&amp;rft.au=Simha%2C+Vinaya&amp;rft_id=http%3A%2F%2Fjournals.sagepub.com%2Fdoi%2F10.4137%2FCCRep.S40196&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Billings, J. K.; Milgraum, S. S.; Gupta, A. K.; Headington, J. T.; Rasmussen, J. E. (December 1987). \"Lipoatrophic panniculitis: a possible autoimmune inflammatory disease of fat. Report of three cases\". <i>Archives of Dermatology</i>. <b>123</b> (12): 1662\u20131666. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archderm.123.12.1662\">10.1001/archderm.123.12.1662</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/3688906\">3688906</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Dermatology&amp;rft.atitle=Lipoatrophic+panniculitis%3A+a+possible+autoimmune+inflammatory+disease+of+fat.+Report+of+three+cases&amp;rft.volume=123&amp;rft.issue=12&amp;rft.pages=1662-1666&amp;rft.date=1987-12&amp;rft_id=info%3Adoi%2F10.1001%2Farchderm.123.12.1662&amp;rft_id=info%3Apmid%2F3688906&amp;rft.aulast=Billings&amp;rft.aufirst=J.+K.&amp;rft.au=Milgraum%2C+S.+S.&amp;rft.au=Gupta%2C+A.+K.&amp;rft.au=Headington%2C+J.+T.&amp;rft.au=Rasmussen%2C+J.+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:3-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:3_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:3_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:3_11-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:3_11-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:3_11-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:3_11-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nolis, Tom (2013). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/doifinder/10.1038/jhg.2013.107\">\"Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies\"</a>. <i>Journal of Human Genetics</i>. <b>59</b> (1): 16\u201323. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/jhg.2013.107\">10.1038/jhg.2013.107</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24152769\">24152769</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Human+Genetics&amp;rft.atitle=Exploring+the+pathophysiology+behind+the+more+common+genetic+and+acquired+lipodystrophies&amp;rft.volume=59&amp;rft.issue=1&amp;rft.pages=16-23&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.1038%2Fjhg.2013.107&amp;rft_id=info%3Apmid%2F24152769&amp;rft.aulast=Nolis&amp;rft.aufirst=Tom&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fdoifinder%2F10.1038%2Fjhg.2013.107&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:4-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:4_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:4_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:4_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:4_12-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:4_12-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Oral, Elif Arioglu; Simha, Vinaya; Ruiz, Elaine; Andewelt, Alexa; Premkumar, Ahalya; Snell, Peter; Wagner, Anthony J.; DePaoli, Alex M.; Reitman, Marc L. (2002-02-21). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1056/NEJMoa012437\">\"Leptin-Replacement Therapy for Lipodystrophy\"</a>. <i>New England Journal of Medicine</i>. <b>346</b> (8): 570\u2013578. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/nejmoa012437\">10.1056/nejmoa012437</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11856796\">11856796</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Leptin-Replacement+Therapy+for+Lipodystrophy&amp;rft.volume=346&amp;rft.issue=8&amp;rft.pages=570-578&amp;rft.date=2002-02-21&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmoa012437&amp;rft_id=info%3Apmid%2F11856796&amp;rft.aulast=Oral&amp;rft.aufirst=Elif+Arioglu&amp;rft.au=Simha%2C+Vinaya&amp;rft.au=Ruiz%2C+Elaine&amp;rft.au=Andewelt%2C+Alexa&amp;rft.au=Premkumar%2C+Ahalya&amp;rft.au=Snell%2C+Peter&amp;rft.au=Wagner%2C+Anthony+J.&amp;rft.au=DePaoli%2C+Alex+M.&amp;rft.au=Reitman%2C+Marc+L.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1056%2FNEJMoa012437&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">H\u00fcbler, A.; Abendroth, K.; Keiner, T.; St\u00f6cker, W.; Kauf, E.; Hein, G.; Stein, G. (1998). \"Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes\". <i>Experimental and Clinical Endocrinology &amp; Diabetes</i>. <b>106</b> (1): 79\u201384. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1055/s-0029-1211955\">10.1055/s-0029-1211955</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9516065\">9516065</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Experimental+and+Clinical+Endocrinology+%26+Diabetes&amp;rft.atitle=Dysregulation+of+insulin-like+growth+factors+in+a+case+of+generalized+acquired+lipoatrophic+diabetes+mellitus+%28Lawrence+Syndrome%29+connected+with+autoantibodies+against+adipocyte+membranes&amp;rft.volume=106&amp;rft.issue=1&amp;rft.pages=79-84&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0029-1211955&amp;rft_id=info%3Apmid%2F9516065&amp;rft.aulast=H%C3%BCbler&amp;rft.aufirst=A.&amp;rft.au=Abendroth%2C+K.&amp;rft.au=Keiner%2C+T.&amp;rft.au=St%C3%B6cker%2C+W.&amp;rft.au=Kauf%2C+E.&amp;rft.au=Hein%2C+G.&amp;rft.au=Stein%2C+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:6-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:6_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:6_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:6_14-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:6_14-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:6_14-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.myalept.com/\">\"Homepage | Myalept\"</a>. <i>www.myalept.com</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-11-07</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.myalept.com&amp;rft.atitle=Homepage+%7C+Myalept&amp;rft_id=http%3A%2F%2Fwww.myalept.com%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bolan, Charles; Oral, Elif Arioglu; Gorden, Phillip; Taylor, Simeon; Leitman, Susan F. (January 2002). \"Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy\". <i>The Journal of Clinical Endocrinology and Metabolism</i>. <b>87</b> (1): 380\u2013384. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1210/jcem.87.1.8176\">10.1210/jcem.87.1.8176</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11788680\">11788680</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Clinical+Endocrinology+and+Metabolism&amp;rft.atitle=Intensive%2C+long-term+plasma+exchange+therapy+for+severe+hypertriglyceridemia+in+acquired+generalized+lipoatrophy&amp;rft.volume=87&amp;rft.issue=1&amp;rft.pages=380-384&amp;rft.date=2002-01&amp;rft_id=info%3Adoi%2F10.1210%2Fjcem.87.1.8176&amp;rft_id=info%3Apmid%2F11788680&amp;rft.aulast=Bolan&amp;rft.aufirst=Charles&amp;rft.au=Oral%2C+Elif+Arioglu&amp;rft.au=Gorden%2C+Phillip&amp;rft.au=Taylor%2C+Simeon&amp;rft.au=Leitman%2C+Susan+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:10-16\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:10_16-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:10_16-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Diker-Cohen, Talia; Cochran, Elaine; Gorden, Phillip; Brown, Rebecca J. (2015-05-01). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4422900\">\"Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin\"</a>. <i>The Journal of Clinical Endocrinology &amp; Metabolism</i>. <b>100</b> (5): 1802\u20131810. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1210/jc.2014-4491\">10.1210/jc.2014-4491</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4422900\">4422900</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Clinical+Endocrinology+%26+Metabolism&amp;rft.atitle=Partial+and+Generalized+Lipodystrophy%3A+Comparison+of+Baseline+Characteristics+and+Response+to+Metreleptin&amp;rft.volume=100&amp;rft.issue=5&amp;rft.pages=1802-1810&amp;rft.date=2015-05-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4422900&amp;rft_id=info%3Adoi%2F10.1210%2Fjc.2014-4491&amp;rft.aulast=Diker-Cohen&amp;rft.aufirst=Talia&amp;rft.au=Cochran%2C+Elaine&amp;rft.au=Gorden%2C+Phillip&amp;rft.au=Brown%2C+Rebecca+J.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4422900&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cunningham, Julia; Nadal, Rosa; Broome, Catherine (2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://linkinghub.elsevier.com/retrieve/pii/S000293431730503X\">\"Acquired Generalized Lipodystrophy Following Immune Thrombocytopenia\"</a>. <i>The American Journal of Medicine</i>. <b>130</b> (10): e445\u2013e446. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.amjmed.2017.04.035\">10.1016/j.amjmed.2017.04.035</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28549922\">28549922</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Medicine&amp;rft.atitle=Acquired+Generalized+Lipodystrophy+Following+Immune+Thrombocytopenia&amp;rft.volume=130&amp;rft.issue=10&amp;rft.pages=e445-e446&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2017.04.035&amp;rft_id=info%3Apmid%2F28549922&amp;rft.aulast=Cunningham&amp;rft.aufirst=Julia&amp;rft.au=Nadal%2C+Rosa&amp;rft.au=Broome%2C+Catherine&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS000293431730503X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Patni, Nivedita; Xing, Chao; Agarwal, Anil K.; Garg, Abhimanyu (2017-09-01). <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.38341/abstract\">\"Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C\"</a>. <i>American Journal of Medical Genetics Part A</i>. <b>173</b> (9): 2517\u20132521. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/ajmg.a.38341\">10.1002/ajmg.a.38341</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5593256\">5593256</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28686329\">28686329</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Medical+Genetics+Part+A&amp;rft.atitle=Juvenile-onset+generalized+lipodystrophy+due+to+a+novel+heterozygous+missense+LMNA+mutation+affecting+lamin+C&amp;rft.volume=173&amp;rft.issue=9&amp;rft.pages=2517-2521&amp;rft.date=2017-09-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5593256&amp;rft_id=info%3Apmid%2F28686329&amp;rft_id=info%3Adoi%2F10.1002%2Fajmg.a.38341&amp;rft.aulast=Patni&amp;rft.aufirst=Nivedita&amp;rft.au=Xing%2C+Chao&amp;rft.au=Agarwal%2C+Anil+K.&amp;rft.au=Garg%2C+Abhimanyu&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1002%2Fajmg.a.38341%2Fabstract&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AAcquired+generalized+lipodystrophy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Acquired_generalized_lipodystrophy&amp;action=edit&amp;section=12\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<table class=\"infobox\" style=\"width:22em;width:100%; margin:0 0 0.5em 0;\"><tbody><tr><th scope=\"row\">Classification</th><td style=\"text-align:left;\">\n<div style=\"position:relative; float:right; font-size:0.8em;\"><a href=\"https://www.wikidata.org/wiki/Q4674772\" class=\"extiw\" title=\"d:Q4674772\">D</a></div><div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems\" title=\"International Statistical Classification of Diseases and Related Health Problems\">ICD</a>-<a href=\"/wiki/ICD-10\" title=\"ICD-10\">10</a></b>: E88.1</li></ul></div></td></tr><tr><th scope=\"row\">External resources</th><td style=\"text-align:left;\">\n<div class=\"hlist hlist-separated\" style=\"text-align:left;\"><ul><li><b><a href=\"/wiki/Orphanet\" title=\"Orphanet\">Orphanet</a></b>: <a rel=\"nofollow\" class=\"external text\" href=\"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=79086\">79086</a></li></ul></div></td></tr></tbody></table>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Disorders_of_subcutaneous_fat_(M79.3,_729.3)\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Disorders_of_subcutaneous_fat\" title=\"Template:Disorders of subcutaneous fat\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Disorders_of_subcutaneous_fat\" title=\"Template talk:Disorders of subcutaneous fat\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Disorders_of_subcutaneous_fat&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Disorders_of_subcutaneous_fat_(M79.3,_729.3)\" style=\"font-size:114%;margin:0 4em\">Disorders of <a href=\"/wiki/Subcutaneous_fat\" class=\"mw-redirect\" title=\"Subcutaneous fat\">subcutaneous fat</a>  (<a href=\"/wiki/ICD-10_Chapter_XIII:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#(M60\u2013M79)_Soft_tissue_disorders\" title=\"ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue\">M79.3</a>, <a href=\"/wiki/List_of_ICD-9_codes_710%E2%80%93739:_diseases_of_the_musculoskeletal_system_and_connective_tissue#Rheumatism,_excluding_the_back_(725\u2013729)\" title=\"List of ICD-9 codes 710\u2013739: diseases of the musculoskeletal system and connective tissue\">729.3</a>)</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Panniculitis\" title=\"Panniculitis\">Panniculitis</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Lobular</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li>without vasculitis\n<ul><li><a href=\"/wiki/Cold_panniculitis\" class=\"mw-redirect\" title=\"Cold panniculitis\">Cold</a></li>\n<li><a href=\"/wiki/Cytophagic_histiocytic_panniculitis\" class=\"mw-redirect\" title=\"Cytophagic histiocytic panniculitis\">Cytophagic histiocytic</a></li>\n<li><a href=\"/wiki/Factitial_panniculitis\" class=\"mw-redirect\" title=\"Factitial panniculitis\">Factitial</a></li>\n<li><a href=\"/wiki/Gouty_panniculitis\" class=\"mw-redirect\" title=\"Gouty panniculitis\">Gouty</a></li>\n<li><a href=\"/wiki/Pancreatic_panniculitis\" class=\"mw-redirect\" title=\"Pancreatic panniculitis\">Pancreatic</a></li>\n<li><a href=\"/wiki/Traumatic_panniculitis\" class=\"mw-redirect\" title=\"Traumatic panniculitis\">Traumatic</a></li></ul></li></ul>\n<ul><li><i>needle-shaped clefts</i>\n<ul><li><a href=\"/wiki/Subcutaneous_fat_necrosis_of_the_newborn\" title=\"Subcutaneous fat necrosis of the newborn\">Subcutaneous fat necrosis of the newborn</a></li>\n<li><a href=\"/wiki/Sclerema_neonatorum\" title=\"Sclerema neonatorum\">Sclerema neonatorum</a></li>\n<li><a href=\"/wiki/Post-steroid_panniculitis\" class=\"mw-redirect\" title=\"Post-steroid panniculitis\">Post-steroid panniculitis</a></li></ul></li>\n<li><a href=\"/wiki/Lipodermatosclerosis\" title=\"Lipodermatosclerosis\">Lipodermatosclerosis</a></li>\n<li><a href=\"/wiki/Weber%E2%80%93Christian_disease\" title=\"Weber\u2013Christian disease\">Weber\u2013Christian disease</a></li>\n<li><a href=\"/wiki/Lupus_erythematosus_panniculitis\" title=\"Lupus erythematosus panniculitis\">Lupus erythematosus panniculitis</a></li>\n<li><a href=\"/wiki/Sclerosing_lipogranuloma\" class=\"mw-redirect\" title=\"Sclerosing lipogranuloma\">Sclerosing lipogranuloma</a></li></ul>\n<ul><li><i>with vasculitis:</i> <a href=\"/wiki/Nodular_vasculitis\" title=\"Nodular vasculitis\">Nodular vasculitis</a>/<a href=\"/wiki/Erythema_induratum\" title=\"Erythema induratum\">Erythema induratum</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Septal_panniculitis\" title=\"Septal panniculitis\">Septal</a></th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>without vasculitis:</i> <a href=\"/wiki/Alpha-1_antitrypsin_deficiency_panniculitis\" class=\"mw-redirect\" title=\"Alpha-1 antitrypsin deficiency panniculitis\">Alpha-1 antitrypsin deficiency panniculitis</a></li>\n<li><a href=\"/wiki/Erythema_nodosum\" title=\"Erythema nodosum\">Erythema nodosum</a>\n<ul><li><a href=\"/wiki/Acute_erythema_nodosum\" class=\"mw-redirect\" title=\"Acute erythema nodosum\">Acute</a></li>\n<li><a href=\"/wiki/Chronic_erythema_nodosum\" class=\"mw-redirect\" title=\"Chronic erythema nodosum\">Chronic</a></li></ul></li></ul>\n<ul><li><i>with vasculitis:</i> <a href=\"/wiki/Superficial_thrombophlebitis\" title=\"Superficial thrombophlebitis\">Superficial thrombophlebitis</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Lipodystrophy\" title=\"Lipodystrophy\">Lipodystrophy</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\"></div><table class=\"nowraplinks navbox-subgroup\" style=\"border-spacing:0\"><tbody><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Acquired</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i>generalized:</i> <a class=\"mw-selflink selflink\">Acquired generalized lipodystrophy</a></li></ul>\n<ul><li><i>partial:</i> <a href=\"/wiki/Barraquer%E2%80%93Simons_syndrome\" title=\"Barraquer\u2013Simons syndrome\">Acquired partial lipodystrophy</a></li>\n<li><a href=\"/wiki/Centrifugal_abdominal_lipodystrophy\" title=\"Centrifugal abdominal lipodystrophy\">Centrifugal abdominal lipodystrophy</a></li>\n<li><a href=\"/wiki/HIV-associated_lipodystrophy\" title=\"HIV-associated lipodystrophy\">HIV-associated lipodystrophy</a></li>\n<li><a href=\"/wiki/Lipoatrophia_annularis\" title=\"Lipoatrophia annularis\">Lipoatrophia annularis</a></li></ul>\n<ul><li><i>localized:</i> <a href=\"/wiki/Localized_lipodystrophy\" title=\"Localized lipodystrophy\">Localized lipodystrophy</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Congenital</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Congenital_generalized_lipodystrophy\" title=\"Congenital generalized lipodystrophy\">Congenital generalized lipodystrophy</a></li>\n<li><a href=\"/wiki/Familial_partial_lipodystrophy\" title=\"Familial partial lipodystrophy\">Familial partial lipodystrophy</a></li>\n<li><a href=\"/wiki/Marfanoid%E2%80%93progeroid%E2%80%93lipodystrophy_syndrome\" title=\"Marfanoid\u2013progeroid\u2013lipodystrophy syndrome\">Marfanoid\u2013progeroid\u2013lipodystrophy syndrome</a></li>\n<li><a href=\"/wiki/Poland_syndrome\" title=\"Poland syndrome\">Poland syndrome</a></li></ul>\n</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2227\nCached time: 20180918233916\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.408 seconds\nReal time usage: 0.550 seconds\nPreprocessor visited node count: 2005/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 64480/2097152 bytes\nTemplate argument size: 381/2097152 bytes\nHighest expansion depth: 9/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 35969/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.185/10.000 seconds\nLua memory usage: 5.3 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  449.493      1 -total\n 38.41%  172.663      1 Template:Reflist\n 38.03%  170.940      2 Template:Infobox\n 34.89%  156.826      1 Template:Infobox_medical_condition_(new)\n 17.59%   79.053     13 Template:Cite_journal\n 12.82%   57.613      1 Template:Medical_resources\n  9.07%   40.761      3 Template:Cite_book\n  7.00%   31.470      3 Template:Navbox\n  5.89%   26.495      1 Template:Disorders_of_subcutaneous_fat\n  4.55%   20.465      4 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:21894306-0!canonical and timestamp 20180918233916 and revision id 845118550\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%AD%D8%AB%D9%84_%D8%B4%D8%AD%D9%85%D9%8A_%D9%85%D9%83%D8%AA%D8%B3%D8%A8_%D9%85%D8%AA%D8%B9%D9%85%D9%85","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u062d\u062b\u0644 \u0634\u062d\u0645\u064a \u0645\u0643\u062a\u0633\u0628 \u0645\u062a\u0639\u0645\u0645"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Lawrence-Syndrom","langname":"German","autonym":"Deutsch","*":"Lawrence-Syndrom"}],"categories":[{"sortkey":"","hidden":"","*":"Infobox_medical_condition_(new)"},{"sortkey":"","*":"Conditions_of_the_subcutaneous_fat"},{"sortkey":"","*":"Syndromes"}],"links":[{"ns":10,"exists":"","*":"Template:Disorders of subcutaneous fat"},{"ns":0,"exists":"","*":"Acute erythema nodosum"},{"ns":0,"exists":"","*":"Adipocyte"},{"ns":0,"exists":"","*":"Adipose tissue"},{"ns":0,"exists":"","*":"Alpha-1 antitrypsin deficiency panniculitis"},{"ns":0,"exists":"","*":"Anti-diabetic medication"},{"ns":0,"exists":"","*":"Antibody"},{"ns":0,"exists":"","*":"Autoimmune hepatitis"},{"ns":0,"exists":"","*":"Autoimmunity"},{"ns":0,"exists":"","*":"Barraquer\u2013Simons syndrome"},{"ns":0,"exists":"","*":"Centrifugal abdominal lipodystrophy"},{"ns":0,"exists":"","*":"Chronic erythema nodosum"},{"ns":0,"exists":"","*":"Cold panniculitis"},{"ns":0,"exists":"","*":"Congenital disorder"},{"ns":0,"exists":"","*":"Congenital generalized lipodystrophy"},{"ns":0,"exists":"","*":"Congenital lipodystrophy"},{"ns":0,"exists":"","*":"Cytokine"},{"ns":0,"exists":"","*":"Cytophagic histiocytic panniculitis"},{"ns":0,"exists":"","*":"Diabetes mellitus"},{"ns":0,"exists":"","*":"Differential diagnosis"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Erythema induratum"},{"ns":0,"exists":"","*":"Erythema nodosum"},{"ns":0,"exists":"","*":"Escherichia coli"},{"ns":0,"exists":"","*":"Facial reconstruction"},{"ns":0,"exists":"","*":"Factitial panniculitis"},{"ns":0,"exists":"","*":"Familial partial lipodystrophy"},{"ns":0,"exists":"","*":"Fasting"},{"ns":0,"exists":"","*":"Fibrate"},{"ns":0,"exists":"","*":"Genetics"},{"ns":0,"exists":"","*":"Glucose"},{"ns":0,"exists":"","*":"Glycated hemoglobin"},{"ns":0,"exists":"","*":"Gouty panniculitis"},{"ns":0,"exists":"","*":"HIV-associated lipodystrophy"},{"ns":0,"exists":"","*":"Homeostasis"},{"ns":0,"exists":"","*":"Hyperlipidemia"},{"ns":0,"exists":"","*":"Hypertriglyceridemia"},{"ns":0,"exists":"","*":"ICD-10"},{"ns":0,"exists":"","*":"ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue"},{"ns":0,"exists":"","*":"Idiopathy"},{"ns":0,"exists":"","*":"Implant (body modification)"},{"ns":0,"exists":"","*":"Infection"},{"ns":0,"exists":"","*":"Inherited disease"},{"ns":0,"exists":"","*":"Insulin"},{"ns":0,"exists":"","*":"Insulin resistance"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"International Statistical Classification of Diseases and Related Health Problems"},{"ns":0,"exists":"","*":"JAK-STAT signaling pathway"},{"ns":0,"exists":"","*":"Juvenile dermatomyositis"},{"ns":0,"exists":"","*":"Lamin"},{"ns":0,"exists":"","*":"Leptin"},{"ns":0,"exists":"","*":"Leptin receptor"},{"ns":0,"exists":"","*":"Lipid"},{"ns":0,"exists":"","*":"Lipoatrophia annularis"},{"ns":0,"exists":"","*":"Lipodermatosclerosis"},{"ns":0,"exists":"","*":"Lipodystrophy"},{"ns":0,"exists":"","*":"List of ICD-9 codes 710\u2013739: diseases of the musculoskeletal system and connective tissue"},{"ns":0,"exists":"","*":"List of cutaneous conditions"},{"ns":0,"exists":"","*":"Liver"},{"ns":0,"exists":"","*":"Localized lipodystrophy"},{"ns":0,"exists":"","*":"Lupus erythematosus panniculitis"},{"ns":0,"exists":"","*":"Lymphoma"},{"ns":0,"exists":"","*":"Magnetic resonance imaging"},{"ns":0,"exists":"","*":"Marfanoid\u2013progeroid\u2013lipodystrophy syndrome"},{"ns":0,"exists":"","*":"Metabolic syndrome"},{"ns":0,"exists":"","*":"Metformin"},{"ns":0,"exists":"","*":"Methionine"},{"ns":0,"exists":"","*":"Metreleptin"},{"ns":0,"exists":"","*":"Muscle"},{"ns":0,"exists":"","*":"Nodular vasculitis"},{"ns":0,"exists":"","*":"OCLC"},{"ns":0,"exists":"","*":"Orphanet"},{"ns":0,"exists":"","*":"Pancreatic panniculitis"},{"ns":0,"exists":"","*":"Pancreatitis"},{"ns":0,"exists":"","*":"Panniculitis"},{"ns":0,"exists":"","*":"Partial lipodystrophy"},{"ns":0,"exists":"","*":"Plasmapheresis"},{"ns":0,"exists":"","*":"Poland syndrome"},{"ns":0,"exists":"","*":"Post-steroid panniculitis"},{"ns":0,"exists":"","*":"Prognosis"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Receptor (biochemistry)"},{"ns":0,"exists":"","*":"Rheumatoid arthritis"},{"ns":0,"exists":"","*":"Risk evaluation and mitigation strategy"},{"ns":0,"exists":"","*":"Sclerema neonatorum"},{"ns":0,"exists":"","*":"Sclerosing lipogranuloma"},{"ns":0,"exists":"","*":"Septal panniculitis"},{"ns":0,"exists":"","*":"Sj\u00f6gren syndrome"},{"ns":0,"exists":"","*":"Skin condition"},{"ns":0,"exists":"","*":"Statin"},{"ns":0,"exists":"","*":"Subcutaneous fat"},{"ns":0,"exists":"","*":"Subcutaneous fat necrosis of the newborn"},{"ns":0,"exists":"","*":"Subcutaneous tissue"},{"ns":0,"exists":"","*":"Superficial thrombophlebitis"},{"ns":0,"exists":"","*":"Systemic lupus erythematosus"},{"ns":0,"exists":"","*":"Thiazolidinedione"},{"ns":0,"exists":"","*":"Traumatic panniculitis"},{"ns":0,"exists":"","*":"Triglyceride"},{"ns":0,"exists":"","*":"Weber\u2013Christian disease"},{"ns":0,"exists":"","*":"Xanthoma"},{"ns":11,"exists":"","*":"Template talk:Disorders of subcutaneous fat"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical condition (new)"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Rp"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Medical resources"},{"ns":10,"exists":"","*":"Template:Hlist"},{"ns":10,"exists":"","*":"Template:Str find"},{"ns":10,"exists":"","*":"Template:Disorders of subcutaneous fat"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:String2"},{"ns":828,"exists":"","*":"Module:WikidataIB/sandbox"},{"ns":828,"exists":"","*":"Module:Complex date"},{"ns":828,"exists":"","*":"Module:I18n/complex date"},{"ns":828,"exists":"","*":"Module:Ordinal"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Roman"},{"ns":828,"exists":"","*":"Module:ISOdate"},{"ns":828,"exists":"","*":"Module:DateI18n"},{"ns":828,"exists":"","*":"Module:I18n/date"},{"ns":828,"exists":"","*":"Module:Calendar"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:WikidataIB/i18n"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Navbox"}],"images":["Lock-green.svg"],"externallinks":["https://dx.doi.org/10.3109/10428194.2015.1040015","//doi.org/10.3109/10428194.2015.1040015","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4755279","//www.ncbi.nlm.nih.gov/pubmed/25864863","https://dx.doi.org/10.1056/NEJMra025261","//doi.org/10.1056/nejmra025261","//www.ncbi.nlm.nih.gov/pubmed/15028826","http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=79086","http://linkinghub.elsevier.com/retrieve/pii/S0889852916300706","//doi.org/10.1016/j.ecl.2016.06.012","//www.ncbi.nlm.nih.gov/pubmed/27823605","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4108221","//doi.org/10.4158/endp.19.1.v767575m65p5mr06","//www.ncbi.nlm.nih.gov/pubmed/23435042","https://www.worldcat.org/oclc/995848612","//www.worldcat.org/oclc/995848612","http://journals.sagepub.com/doi/10.4137/CCRep.S40196","//doi.org/10.4137/ccrep.s40196","//doi.org/10.1001/archderm.123.12.1662","//www.ncbi.nlm.nih.gov/pubmed/3688906","http://www.nature.com/doifinder/10.1038/jhg.2013.107","//doi.org/10.1038/jhg.2013.107","//www.ncbi.nlm.nih.gov/pubmed/24152769","https://dx.doi.org/10.1056/NEJMoa012437","//doi.org/10.1056/nejmoa012437","//www.ncbi.nlm.nih.gov/pubmed/11856796","//doi.org/10.1055/s-0029-1211955","//www.ncbi.nlm.nih.gov/pubmed/9516065","http://www.myalept.com/","//doi.org/10.1210/jcem.87.1.8176","//www.ncbi.nlm.nih.gov/pubmed/11788680","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4422900","//doi.org/10.1210/jc.2014-4491","http://linkinghub.elsevier.com/retrieve/pii/S000293431730503X","//doi.org/10.1016/j.amjmed.2017.04.035","//www.ncbi.nlm.nih.gov/pubmed/28549922","http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.38341/abstract","//doi.org/10.1002/ajmg.a.38341","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5593256","//www.ncbi.nlm.nih.gov/pubmed/28686329","http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79086"],"sections":[{"toclevel":1,"level":"2","line":"Symptoms","number":"1","index":"1","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":4253,"anchor":"Symptoms"},{"toclevel":1,"level":"2","line":"Cause","number":"2","index":"2","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":6901,"anchor":"Cause"},{"toclevel":2,"level":"3","line":"Panniculitis-associated AGL","number":"2.1","index":"3","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":8277,"anchor":"Panniculitis-associated_AGL"},{"toclevel":2,"level":"3","line":"Autoimmune-associated AGL","number":"2.2","index":"4","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":8695,"anchor":"Autoimmune-associated_AGL"},{"toclevel":2,"level":"3","line":"Idiopathic AGL","number":"2.3","index":"5","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":9172,"anchor":"Idiopathic_AGL"},{"toclevel":1,"level":"2","line":"Mechanism","number":"3","index":"6","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":9435,"anchor":"Mechanism"},{"toclevel":1,"level":"2","line":"Diagnosis","number":"4","index":"7","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":11844,"anchor":"Diagnosis"},{"toclevel":1,"level":"2","line":"Treatment and prognosis","number":"5","index":"8","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":13193,"anchor":"Treatment_and_prognosis"},{"toclevel":1,"level":"2","line":"Recent research","number":"6","index":"9","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":16685,"anchor":"Recent_research"},{"toclevel":1,"level":"2","line":"See also","number":"7","index":"10","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":19943,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"11","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":20049,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"9","index":"12","fromtitle":"Acquired_generalized_lipodystrophy","byteoffset":20078,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Acquired generalized lipodystrophy","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q4674772","*":"d:Q4674772"}],"properties":[{"name":"wikibase_item","*":"Q4674772"}]}}